Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different Complications

Key facts

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Principal Investigator

Guangyu Chen, PhD

Shanghai Municipal Science and Technology Commission

Intervention

Complications(other)

Enrollment

33 enrolled

Eligibility

1 years · All sexes

Timeline

2015 – 2016

Study locations (1)

• Ethics Committee of Xinhua Hospital, Shanghai, Shanghai Municipality, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Short bowel syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07319832
  A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome
  Takeda
• RECRUITINGPHASE3NCT07197944
  Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
  Zealand Pharma
• ENROLLING BY INVITATIONPHASE3NCT07228403
  Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
  Zealand Pharma
• RECRUITINGPHASE3NCT06973304
  A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
  Takeda
• RECRUITINGPHASE2NCT06904872
  Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
  Napo Therapeutics, S.p.A.
• RECRUITINGNANCT06877923
  Elemental 028 Extra Case Studies
  Nutricia UK Ltd
• RECRUITINGEARLY PHASE1NCT06326645
  Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome
  Lindsey Russell, MD
• RECRUITINGNCT06771505
  SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)
  Hospices Civils de Lyon

See all trials for Short bowel syndrome →